ARCHIVES

Neutron Therapy Contracts Wind Down Next Year; DCT To Consider Whether To Continue Support

This article is from The Cancer Letter archive.

Vol. 14 No. 13 | March 25, 1988

Download PDF Visit The Full Archive

Related Articles

Rosenberg: Immunotherapy May Have Broad Potential

June 24, 2005

Phase III Trial Data: Lenvatinib Extends PFS by Over 14 Months

June 27, 2014

Susan Sieber, Former NCI Communications Chief, Dead.

January 25, 2002

IOM Report: Seek More Comment From Public On Priorities, NIH Told

July 17, 1998

Payline Not Set For CCOPs Yet In Recompetition

March 1, 1991

Et2’s Referral Guidelines

July 23, 1993